ConductScience.org, home

Paper2876233

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure.

Cowley AJ and 4 others. Lancet, 1986. Cited by 78 papers, by iCite.

Cite this record

ConductScience Library. Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure. Papers, record 2876233. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2876233

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure.
PubMed
Journal
Lancet
PubMed
Year
1986
PubMed
Publication types
Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
78
iCite
Relative citation ratio, by iCite
3.58
iCite
Revised in PubMed
2019-06-11
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cowley AJA J
2Stainer KK
3Wynne RDR D
4Rowley JMJ M
5Hampton JRJ R

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CaptoprilMajor topic
FurosemideMajor topic
Heart FailureMajor topic
Aged
Clinical Trials as Topic
Double-Blind Method
Drug Therapy, Combination
Exercise Test
Humans
Male
Middle Aged
Random Allocation

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT02689180Effect of Furosemide Withdraw in Stable Chronic Heart Failure OutpatientsBackground

Source ClinicalTrials.gov

Download CSV of trials

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 78 citations.

PMIDTitleJournalYearIn PapersSource
27722846Drug therapy of chronic heart failure.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/27722846PubMed
24384895Multidrug and optimal heart failure therapy prescribing in older general practice populations: a clinical data linkage study.BMJ Open2014https://conductscience.org/library/papers/24384895PubMed
22699923Congestion is the driving force behind heart failure.Curr Heart Fail Rep2012https://conductscience.org/library/papers/22699923PubMed
21887112Key role of congestion in natural history of heart failure.Int J Gen Med2011https://conductscience.org/library/papers/21887112PubMed
21403798Diuretics as pathogenetic treatment for heart failure.Int J Gen Med2011https://conductscience.org/library/papers/21403798PubMed
20556804Loop diuretic therapy in heart failure: the need for solid evidence on a fluid issue.Clin Cardiol2010https://conductscience.org/library/papers/20556804PubMed
11986906Diuretics in the treatment of patients who present congestive heart failure and hypertension.J Hum Hypertens2002https://conductscience.org/library/papers/11986906PubMed
10980815Symptomatic systolic ventricular failure.Curr Cardiol Rep1999https://conductscience.org/library/papers/10980815PubMed
8882374Novel drugs and current therapeutic approaches in the treatment of heart failure.Drugs1996https://conductscience.org/library/papers/8882374PubMed
8129862Phosphodiesterase inhibitors. Do the risks outweight the benefits?Drug Saf1993https://conductscience.org/library/papers/8129862PubMed
8011560Postinfarct heart failure: role of diuretic therapy.Cardiovasc Drugs Ther1993https://conductscience.org/library/papers/8011560PubMed
7946811How do changes in lifestyle complement medical treatment in heart failure?Br Heart J1994https://conductscience.org/library/papers/7946811PubMed
7946764Results of clinical trials with diuretics in heart failure.Br Heart J1994https://conductscience.org/library/papers/7946764PubMed
7488449Failure of "effective" treatment for heart failure to improve normal customary activity.Br Heart J1995https://conductscience.org/library/papers/7488449PubMed
3075041The place of ACE inhibitors in the current treatment of chronic heart failure.Postgrad Med J1988https://conductscience.org/library/papers/3075041PubMed
2686737Comparison of the immediate and long-term effects of captopril and isosorbide dinitrate as adjunctive treatment in mild heart failure.Br J Clin Pharmacol1989https://conductscience.org/library/papers/2686737PubMed
1712715Acute and long term effects of loop diuretics in heart failure.Drugs1991https://conductscience.org/library/papers/1712715PubMed
1450090A comparison of the effects of captopril and flosequinan in patients with severe heart failure.Cardiovasc Drugs Ther1992https://conductscience.org/library/papers/1450090PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2876233

GET https://conductscience.org/api/papers/v1/2876233/authors